DWP 215
Alternative Names: DWJ-215; DWP-215Latest Information Update: 25 Oct 2022
At a glance
- Originator Daewoong Pharmaceutical; Yonsei University
- Class Sensory system agents
- Mechanism of Action Ion channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hearing loss
Most Recent Events
- 20 Oct 2022 Discontinued for Hearing loss in South Korea (unspecified route) (Daewoong pipeline, October 2022)
- 12 Jun 2020 Early research in Hearing loss in South Korea prior to June 2020 (Daewoong Pharmaceutical pipeline, June 2020)